Christoph Stoller – President & Adrian van den Hoven – Director General, Medicines for Europe

Christoph Stoller, the recently appointed president of Medicines for Europe, outlines the mission of his presidency, how the association and its members are working to tackle the issue of drug shortages across the continent, and the crucial importance of establishing a high-level dialogue between industry and governments. Adrian van den Hoven, the organization’s director general, adds his take on the major challenges facing the generics industry today.   What is the mission of your presidency? Christoph Stoller (CS): For high-quality medicines to be in the hands of patients when they need them. Over the coming two years, I will focus on sustainable access to generics, biosimilars and value-added medicines and the prevention of medicine shortages. I plan to do this by optimising the regulatory framework, fostering a sustainable and responsive industry, securing European leadership in medicines and API manufacturing, and incentivising the digital transformation of our healthcare systems.
I am calling on the European Commission and its newly elected President Ursula von der Leyen to take action on sustainable access to medicines for patients Christoph Stoller
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report